Literature DB >> 12372784

Sustained activation of MAPK/ERKs signaling pathway in cystic kidneys from bcl-2 -/- mice.

Christine M Sorenson1, Nader Sheibani.   

Abstract

Cell proliferation, survival, and differentiation are carefully orchestrated processes during nephrogenesis that become aberrant during renal cyst formation. Signaling through focal adhesion kinase (FAK) impacts these processes, although its role during nephrogenesis requires further delineation. We previously demonstrated that phosphorylation of FAK and paxillin is not downregulated in cystic kidneys from B cell lymphoma/leukemia-2 (bcl-2) -/- mice. Here we examine whether FAK downstream signaling pathways are affected in these cystic kidneys. Cystic kidneys from bcl-2 -/- mice exhibited sustained phosphorylation of Src and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK, ERK1). However, similar levels of expression were noted for phosphorylated c-Jun NH(2)-terminal kinase, phosphatidylinositol-3-kinase, and its target protein kinase B/ATP-dependent tyrosine kinase in kidneys from postnatal day 20 bcl-2 +/+ and bcl-2 -/- mice. We also examined expression of the adapter protein Shc, implicated in growth and apoptosis. Expression of p66(Shc) decreases to low levels in postnatal kidneys, whereas p52/p46(Shc) was constitutively expressed during nephrogenesis. Shc expression was similar in normal and cystic kidneys. Therefore, sustained activation of MAPK/ERKs through the Src/FAK pathway may contribute to the hyperproliferation observed in cystic kidneys from bcl-2 -/- mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372784     DOI: 10.1152/ajprenal.00380.2001

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  8 in total

1.  Opposing effects of bim and bcl-2 on lung endothelial cell migration.

Authors:  Cathy Grutzmacher; SunYoung Park; Tammy L Elmergreen; Yixin Tang; Elizabeth A Scheef; Nader Sheibani; Christine M Sorenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-23       Impact factor: 5.464

2.  Bim is responsible for the inherent sensitivity of the developing retinal vasculature to hyperoxia.

Authors:  Shoujian Wang; SunYoung Park; Ping Fei; Christine M Sorenson
Journal:  Dev Biol       Date:  2010-11-01       Impact factor: 3.582

3.  Recruitment of Nox4 to a plasma membrane scaffold is required for localized reactive oxygen species generation and sustained Src activation in response to insulin-like growth factor-I.

Authors:  Gang Xi; Xin-Chun Shen; Christine Wai; David R Clemmons
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

4.  Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes.

Authors:  Cathy Grutzmacher; SunYoung Park; Yun Zhao; Margaret E Morrison; Nader Sheibani; Christine M Sorenson
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-17

5.  Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD.

Authors:  Frank Park; William E Sweeney; Guangfu Jia; Talha Akbulut; Benjamin Mueller; J Russell Falck; Saritha Birudaraju; Richard J Roman; Ellis D Avner
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-07

6.  Rescue of renal hypoplasia and cystic dysplasia in Bcl-2 -/- mice expressing Bcl-2 in ureteric bud derived epithelia.

Authors:  Shuji Kondo; Mason G Oakes; Christine M Sorenson
Journal:  Dev Dyn       Date:  2008-09       Impact factor: 3.780

7.  Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease.

Authors:  Priyanka Pandey; Benedikt Brors; Prashant K Srivastava; Andrea Bott; Susanne N E Boehn; Herrmann-Josef Groene; Norbert Gretz
Journal:  BMC Genomics       Date:  2008-12-23       Impact factor: 3.969

8.  Low-level laser therapy regulates microglial function through Src-mediated signaling pathways: implications for neurodegenerative diseases.

Authors:  Sheng Song; Feifan Zhou; Wei R Chen
Journal:  J Neuroinflammation       Date:  2012-09-18       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.